LCM
GNCA

Laurion Capital Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Laurion Capital Management’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,550
Closed -$86K – 1702
2018
Q2 		$86K Buy
+12,550
New +$93.9K ﹤0.01% 1257

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laurion Capital Management's GNCA Position: Q3 2018 in Review

Laurion Capital Management sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2018, closing a stake of 12,550 shares — an estimated $86K sold.

Laurion Capital Management first reported a position in GNCA in Q2 2018 and held it in 1 quarter. The position peaked at $86K in Q2 2018. 48 funds tracked by Wall St. Rank hold GNCA as of Q3 2018.

  • Laurion Capital Management reported no remaining Genocea Biosciences, Inc. position as of Q3 2018 after selling out during the quarter.
  • Laurion Capital Management sold 12,550 Genocea Biosciences, Inc. shares in Q3 2018, an estimated $86K.
  • Laurion Capital Management first reported a position in Genocea Biosciences, Inc. in Q2 2018 and held it in 1 quarter.
  • Laurion Capital Management's Genocea Biosciences, Inc. position peaked at $86K in Q2 2018.
  • 48 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2018.

Based on Laurion Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.